比例ハザード回帰分析
WordNet
- give pleasant proportions to; "harmonize a building with those surrounding it"
- the relation between things (or parts of things) with respect to their comparative quantity, magnitude, or degree; "an inordinate proportion of the book is given over to quotations"; "a dry martini has a large proportion of gin" (同)ratio
- adjust in size relative to other things
- the quotient obtained when the magnitude of a part is divided by the magnitude of the whole
- magnitude or extent; "a building of vast proportions" (同)dimension
- harmonious arrangement or relation of parts or elements within a whole (as in a design); "in all perfectly beautiful objects there is found the opposition of one part to another and a reciprocal balance"- John Ruskin (同)proportionality, balance
- an investigation of the component parts of a whole and their relations in making up the whole
- the abstract separation of a whole into its constituent parts in order to study the parts and their relations (同)analytic thinking
- a branch of mathematics involving calculus and the theory of limits; sequences and series and integration and differentiation
- a form of literary criticism in which the structure of a piece of writing is analyzed
- the use of closed-class words instead of inflections: e.g., `the father of the bride instead of `the brides father
- a source of danger; a possibility of incurring loss or misfortune; "drinking alcohol is a health hazard" (同)jeopardy, peril, risk, endangerment
- an obstacle on a golf course
- (psychiatry) a defense mechanism in which you flee from reality by assuming a more infantile state
- returning to a former state (同)regress, reversion, retrogression, retroversion
- the relation between selected values of x and observed values of y (from which the most probable value of y can be predicted for any value of x) (同)simple regression, regression toward the mean, statistical regression
- having a constant ratio
- one of the quantities in a mathematical proportion
- properly related in size or degree or other measurable characteristics; usually followed by `to; "the punishment ought to be proportional to the crime"; "earnings relative to production" (同)relative
PrepTutorEJDIC
- 《the~》(…に対する…の)『割合』,比率《+『of』+『名』+『to』+『名』》 / 〈U〉(…との)『調和』,均衡《+『to』+『名』》 / 〈C〉部分;割り前,分け前 / 《複数形で》大きさ / 〈U〉比例 / …‘の'調和をとる;(…に)…‘を'釣り合わせる《+『名』+『to』+『名』》
- (内容・状況などの)『分析』,分解;(詳細な)検討 / (化学・物理で)分析;《米》(心理学で)[精神]分析;(数学で)解析
- 危険,冒険;(…にとっての)危険物《+『to』+『名』》 / (ゴルフや障害レースの)障害物 / 〈生命・財産など〉‘を'危険にさらす / …‘を'思い切ってする(言う)
- 後退;退化,退歩
- 比例の,比例による;(…と)比例として《+『to』+『名』》 / 釣り合った,調和した;(…に)釣り合った《+『to』+『名』》
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Prostate Cancer (PCa) Risk Variants and Risk of Fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
- Shui IM1, Lindström S2, Kibel AS3, Berndt SI4, Campa D5, Gerke T2, Penney KL6, Albanes D4, Berg C7, Bueno-de-Mesquita HB8, Chanock S9, Crawford ED10, Diver WR11, Gapstur SM11, Gaziano JM12, Giles GG13, Henderson B14, Hoover R4, Johansson M15, Le Marchand L16, Ma J6, Navarro C17, Overvad K18, Schumacher FR14, Severi G19, Siddiq A20, Stampfer M6, Stevens VL11, Travis RC21, Trichopoulos D22, Vineis P23, Mucci LA2, Yeager M9, Giovannucci E2, Kraft P2.Author information 1Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA. Electronic address: ishui@hsph.harvard.edu.2Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA.3Department of Surgery, Division of Urology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.4Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.5Genomic Epidemiology Group, German Cancer Research Center (Deutsches Krebsforschungszentrum), Heidelberg, Germany.6Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.7Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins Medicine, Baltimore, MD, USA.8National Institute for Public Health and the Environment, Bilthoven, The Netherlands; Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands; School of Public Health, Imperial College London, London, United Kingdom.9Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Gaithersburg, MD, USA.10Urologic Oncology, University of Colorado, Denver, CO, USA.11Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA.12Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA; Division of Aging, Brigham and Women's Hospital, Boston, MA, USA.13Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.14Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.15International Agency for Research on Cancer, Lyon, France; Department of Biobank Research, Umeå University, Umeå, Sweden.16Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.17Department of Epidemiology, Murcia Regional Health Authority, Murcia, Spain; Department of Health and Social Sciences, Universidad de Murcia, Murcia, Spain.18Department of Public Health, Aarhus University, Aarhus, Denmark.19Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia; HuGeF Foundation, Torino, Italy.20Department of Genomics of Common Disease, Imperial College London, London, United Kingdom.21Cancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom.22Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA; Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece; Hellenic Health Foundation, Athens, Greece.23HuGeF Foundation, Torino, Italy; School of Public Health, Imperial College London, London, United Kingdom.AbstractBACKGROUND: Screening and diagnosis of prostate cancer (PCa) is hampered by an inability to predict who has the potential to develop fatal disease and who has indolent cancer. Studies have identified multiple genetic risk loci for PCa incidence, but it is unknown whether they could be used as biomarkers for PCa-specific mortality (PCSM).
- European urology.Eur Urol.2014 Jun;65(6):1069-75. doi: 10.1016/j.eururo.2013.12.058. Epub 2014 Jan 4.
- BACKGROUND: Screening and diagnosis of prostate cancer (PCa) is hampered by an inability to predict who has the potential to develop fatal disease and who has indolent cancer. Studies have identified multiple genetic risk loci for PCa incidence, but it is unknown whether they could be used as biomar
- PMID 24411283
- APOE ε4 and the risk for Alzheimer disease and cognitive decline in African Americans and Yoruba.
- Hendrie HC1, Murrell J2, Baiyewu O3, Lane KA4, Purnell C5, Ogunniyi A6, Unverzagt FW7, Hall K7, Callahan CM1, Saykin AJ8, Gureje O3, Hake A9, Foroud T10, Gao S4.Author information 1Indiana University Center for Aging Research, Indianapolis, Indiana, USA.2Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.3Department of Psychiatry, College of Medicine, University of Ibadan, Ibadan, Nigeria.4Department of Biostatistics, Indiana University School of Medicine, Indianapolis, Indiana, USA.5Regenstrief Institute, Inc., Indianapolis, Indiana, USA.6Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.7Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana, USA.8Department of Radiology and Imaging Services, Indiana University School of Medicine, Indianapolis, Indiana, USA.9Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA.10Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.AbstractABSTRACT Background: There is little information on the association of the APOEe4 allele and AD risk in African populations. In previous analyses from the Indianapolis-Ibadan dementia project, we have reported that APOE ε4 increased the risk for Alzheimer's disease (AD) in African Americans but not in Yoruba. This study represents a replication of this earlier work using enriched cohorts and extending the analysis to include cognitive decline. Methods: In this longitudinal study of two community dwelling cohorts of elderly Yoruba and African Americans, APOE genotyping was conducted from blood samples taken on or before 2001 (1,871 African Americans & 2,200 Yoruba). Mean follow up time was 8.5 years for African Americans and 8.8 years for Yoruba. The effects of heterozygosity or homozygosity of ε4 and of the possession of e4 on time to incident AD and on cognitive decline were determined using Cox's proportional hazards regression and mixed effects models. Results: After adjusting for covariates, one or two copies of the APOE ε4 allele were significant risk factors for incident AD (p < 0.0001) and cognitive decline in the African-American population (p < 0001). In the Yoruba, only homozygosity for APOE ε4 was a significant risk factor for AD (p = 0.0002) but not for cognitive decline (p = 0.2346), however, possession of an e4 allele was significant for both incident AD (p = 0.0489) and cognitive decline (p = 0.0425). Conclusions: In this large longitudinal comparative study, APOE ε4 had a significant, but weaker, effect on incident AD and on cognitive decline in Yoruba than in African Americans. The reasons for these differences remain unclear.
- International psychogeriatrics / IPA.Int Psychogeriatr.2014 Jun;26(6):977-85. doi: 10.1017/S1041610214000167. Epub 2014 Feb 24.
- ABSTRACT Background: There is little information on the association of the APOEe4 allele and AD risk in African populations. In previous analyses from the Indianapolis-Ibadan dementia project, we have reported that APOE ε4 increased the risk for Alzheimer's disease (AD) in African Americans but not
- PMID 24565289
- Management and outcomes for elderly women with vulvar cancer over time.
- Rauh-Hain J1, Clemmer J, Clark R, Bradford L, Growdon W, Goodman A, Boruta D 2nd, Dizon D, Schorge J, Del Carmen M.Author information 1Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Boston, MA, USA.AbstractOBJECTIVE: To examine changes over time in survival and treatment for women diagnosed with vulvar squamous cell carcinoma included in the Surveillance, Epidemiology, and End Results (SEER) Program.
- BJOG : an international journal of obstetrics and gynaecology.BJOG.2014 May;121(6):719-27. doi: 10.1111/1471-0528.12580. Epub 2014 Feb 24.
- OBJECTIVE: To examine changes over time in survival and treatment for women diagnosed with vulvar squamous cell carcinoma included in the Surveillance, Epidemiology, and End Results (SEER) Program.DESIGN: Retrospective analysis.SETTING: USA, data obtained from the SEER Program for 1988-2009.POPULATI
- PMID 24621118
Japanese Journal
- Aberrant Expression of Keratin 7 in Hepatocytes as a Predictive Marker of Rapid Progression to Hepatic Failure in Asymptomatic Primary Biliary Cirrhosis
- Assessment of Coronary atherosclerosis in patients with familial hypercholesterolemia by coronary computed tomography angiography
- Cardio-Ankle Vascular Index is Independently Associated with Future Cardiovascular Events in Outpatients with Metabolic Disorders
★リンクテーブル★
[★]
- 英
- proportional hazards regression analysis
[★]
[★]
- (生命など)賭する。危険を冒してやる、運任せにかってみる。(金銭など)賭ける、危険にさらす
- 関
- danger、dangerous、harm、hazardous、hazardously、injure、jeopardy、risk、risky、unsafe
[★]
- 関
- involute、involution、involutional、recede、recession、recurrence、recurrent、regress、retraction、retractory、retrogression
[★]
- 関
- balanced、commensurable、commensurate、linear、proportion、proportionally、proportionate、proportionately、rate
[★]
- 関
- anal、analyse、analyses、analytical、analyze、assay、dissect、-metry、solve
[★]